Clinical Trials Protocol Authoring using LLMs

Understand

This report embarks on a mission to revolutionize clinical trial protocol development through the integration of advanced AI technologies.

• With a focus on leveraging the capabilities of generative AI, specifically GPT-4, this initiative aimed to streamline and enhance the efficiency and accuracy of clinical trial protocols.
• The methodology encompassed a detailed analysis and preparation of comprehensive drug and study level metadata, followed by the deployment of GPT-4 for automated protocol section generation.
• Results demonstrated a significant improvement in protocol authoring, highlighted by increases in efficiency, accuracy, and the customization of protocols to specific trial requirements.